Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank71
5Y CAGR+24.4%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
+24.4%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 47.29% |
| 2024 | 15.00% |
| 2023 | 54.76% |
| 2022 | -12.06% |
| 2021 | -48.56% |
| 2020 | 15.89% |
| 2019 | 17.18% |
| 2018 | 125.48% |
| 2017 | 123.15% |
| 2016 | 30.78% |